Sysmex Corporation (SSMXF)

Market Cap	11.44B
Revenue (ttm)	3.19B
Net Income (ttm)	367.57M
Shares Out	n/a
EPS (ttm)	0.59
PE Ratio	31.13
Forward PE	n/a
Dividend	0.10 (0.56%)
Ex-Dividend Date	Sep 27, 2024

Volume	227
Average Volume	37
Open	15.80
Previous Close	15.80
Day's Range	15.80 - 18.60
52-Week Range	14.75 - 55.56
Beta	0.61
RSI	40.50
Earnings Date	Feb 12, 2025

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers;...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1968
• Employees: 10,042
• Stock Exchange: OTCMKTS
• Ticker Symbol: SSMXF

Financial Performance

In 2023, Sysmex's revenue was 461.51 billion, an increase of 12.43% compared to the previous year's 410.50 billion. Earnings were 49.64 billion, an increase of 8.42%.

Financial numbers in JPY